Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not ...

It can be challenging to detect CLL early because it does not cause symptoms in its early stages. CLL can follow two different patterns. Some forms develop very slowly, meaning a person may not ...

The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...

Expert Rev Hematol. 2013;6(4):441-449. In conclusion, although age should generally determine the goal of treatment in CLL, the patient's functional status rather than chronological age can be ...

plus learn some useful tips for managing stress while living with CLL. your outlook the treatment involved feeling unwell in general logistics like finances how your condition might affect your ...

Chronic lymphocytic leukaemia (CLL) often develops very slowly. You might need little or no treatment. Although it is not usually curable, the disease can be under control for many years. But CLL can ...

Susan L. Slager, PhD, discussed the etiology and inherited genetic factors that are associated with the risk of chronic ...

Emotional support from friends significantly enhances resilience during cancer treatment, providing comfort and ... As a ...

The long-term response rate for zanubrutinib was better than ibrutinib in patients with relapsed/refractory chronic ...

Patients with relapsed or refractory chronic lymphocytic leukemia (r/r CLL) saw benefits from treatment with fixed-duration Jaypirca (pirtobrutinib) plus Venclexta (venetoclax; PV) and Jaypirca plus ...

Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...

Data are now accumulating on the feasibility of various treatment options even in unfit patients and there is an increased awareness that the chronological age by itself sometimes does not reflect ...